Posts

NMDA-receptors functional assays for CNS diseases

Whatever your therapeutic area (cognitive disorders, schizophrenia, depression, stroke, neuropathic pain, etc.) you are targeting NMDA receptors and you need to get clean, precise and robust pharmacological profiles of your compounds. For more than 13 years Esther STEIDL and her team have developed multiple assays based on the Multi-Electrode Array technique (MEA recordings) to document […]